Pharus Diagnostics
PrivateLast Round
Early Funding
May 4, 2025
Est. Valuation
$30M
Total Funding Raised
$11M
Company Overview
Pharus Diagnostics is a biotechnology company that develops liquid biopsy tests for the early detection of cancer using proprietary RNA-based technology and machine learning.
Sector
Healthcare & Life Sciences
Verticals
Precision Medicine, Biotechnology, Medical AI, Healthcare Analytics
Business Model
B2B
Customer Profile
Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Pharus Diagnostics Comparables
Compare Pharus Diagnostics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Amplified Sciences | 81% | |
| Mercy BioAnalytics | 77% | |
| Singlera Genomics Inc. | 77% | |
Pharus Diagnostics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | May 4, 2025 | ||||
| Series A Extension | Jul 25, 2022 | ||||
| VC Round | Jul 1, 2022 |
Key People
Founding team and executive leadership
Market signals
Structured signals derived from secondary market and firmographic data.
- May 4, 2025
Completed an early funding round.
- Oct 30, 2024
Monthly visitors grew 115% MoM.
Pharus Diagnostics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Pharus Diagnostics's valuation, stock price, and market status.